Age and platelet count: A simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus

Journal of Viral Hepatitis

Volumn 4, Issue 3, 1997, Pages 199-208

  Poynard, T ^a   Bedossa, P ^b   Bioulac Sage, Paulette ^c   Callard, Patrice ^c   Chevallier, Michele ^c   Degott, Claude ^c   Deugnier, Yves ^c   Fabre, Monique ^c   Reynès, Michel ^c   Voigt, Jean Jacques ^c   Zafrani, Elie Serge ^c   Métreau, Jean Michel ^c   Valla, Dominique ^c   Opolon, Pierre ^c   Dhumeaux, Daniel ^c   Chaput, Jean Claude ^c   Charlotte, Frederic ^c   Lemonnier, Catherine ^c   Babany, Gerard ^c   Agostini, Hélène ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c Groupe Hospitalier Pitié Salpêtricre ^*

Author keywords

Diagnostic evaluation; Hepatitis C; Predictive values

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMAN; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; STATISTICAL MODEL; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0031134389     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00141.x     Document Type: Article

References (10)

1. The METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20: 15-20.
2. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374.
3. Knodell KG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Uepatology 1981; 1: 431-435.
4. Poynard T, Bedossa P, Delfraissy JF, Naveau S, Lemaigre G, Chaput JC. Efficacy of low doses, long-term alpha recombinant interferon in patients with chronic C hepatitis: clinical, biological, histological and immunohistochemical study. Gastroenterol Clin Biol 1991; 15: 615-619.
5. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C and a multicenter study group. Improvement of histological lesions by 18 months therapy with α2B interferon in patients with chronic hepatitis C. A randomized clinical trial. New Engl J Med 1995; 22: 1457-1462.
6. Valla D, Babany G, Ouzan D et al. Prevention of relapse in patients with chronic non A, non B/C hepatitis who respond to alpha-interferon. A controlled multicenter trial of low-dose maintenance therapy. J Hepatol 1994; 21: 774-778.
7. Ouzan D, Skaf R, Andreani T et al. French multicenter control trial of interferon alpha 2a (IFN) in chronic hepatitis C. Does an attack dose (6MU) increase the response rate at 6 and 12 months. J Hepatol 1993; 18S: 53 (abstr).
8. Jouet P, Roudot-Thoraval F, Dhumeaux D, Metreau JM. Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 1994; 106: 686-690.
9. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-278.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1519.